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OBJECTIVES Is the timing of exposure critical for ethanol’s ability to induce cardioprotection?
BACKGROUND Acute ethanol exposure has been reported to mimic ischemic preconditioning in vitro, but it
failed to protect in situ. We hypothesized that these conflicting findings were related to
ethanol’s presence during ischemia in situ.
METHODS The effect on infarct size (triphenyltetrazolium chloride) of acute ethanol exposure (0.35, 0.7,
and 1.4 g/kg IV) 10 min before ischemia was measured in open-chest rabbits after 30 min of
regional ischemia and reperfusion and was compared to ethanol’s ability to reduce infarct size
in isolated hearts in which the timing of ethanol exposure could be varied.
RESULTS Ethanol exposure in situ shortly before ischemia did not reduce infarct size. Moreover,
ethanol abolished protection from both ischemic preconditioning and mitochondrial KATP
channel activation. In contrast, in buffer-perfused hearts exposed to 10 to 50 mmol/liter
ethanol for 5 min followed by washout before ischemia, infarct size was significantly reduced.
When ethanol exposure was prolonged until the end of ischemia in isolated hearts, protection
was abolished. Conversely, protection was seen when ethanol was infused in situ followed by
removal of the heart and perfusion with ethanol-free buffer prior to ischemia in a Langendorff
preparation. When 50 min were allowed to metabolize the ethanol prior to ischemia,
protection could also be shown in situ.
CONCLUSIONS Ethanol exposure followed by washout or sufficient time to metabolize the alcohol prior to
ischemia induces preconditioning-like myocardial protection. However, if present throughout
ischemia, ethanol actually blocks all preconditioning-related protection. (J Am Coll Cardiol
2001;37:601–7) © 2001 by the American College of Cardiology
In recent studies, chronic ethanol consumption induced
cardioprotection against ischemia that persisted for 18 h
after ethanol withdrawal. In hearts isolated from alcohol-fed
guinea pigs, improved contractile recovery and reduced
creatine kinase release after ischemia correlated with trans-
location of protein kinase C (PKC) « (1). This protection
was reminiscent of the “delayed” form of preconditioning in
which a brief ischemic episode triggers protection that
requires 12 to 24 h to develop and lasts for several days (2).
Acute ethanol exposure may mimic classical precondition-
ing as well: ethanol was protective to isolated rat cardiomy-
ocytes, and inhibition of the PKC « isozyme abolished this
protection (3), as seen in ischemic preconditioning (IPC)
(4).
Only one study has tested the effects of acute ethanol
exposure on infarct size in the more clinically relevant in situ
preparation. Surprisingly, intravenous (IV) ethanol infused
shortly prior to ischemia in open-chest dogs did not affect
infarct size (5). Apart from possible species differences and
the controversial role of PKC in IPC in dogs (6–8),
ethanol’s failure to protect might be related to the timing of
its exposure. We therefore tested both in situ and in vitro
whether ethanol could reduce infarction when the exposure
was either transient or sustained and whether ethanol
specifically interfered with the mechanism of IPC.
MATERIALS AND METHODS
All procedures were approved by the Institutional Animal
Care and Use Committee and were in accordance with
recommendations published in the Guide for the Care and
Use of Laboratory Animals, National Academic Press, Wash-
ington, DC, 1996.
New Zealand White rabbits of either sex weighing
between 1.5 and 2.6 kg were anesthetized with IV pento-
barbital sodium (30 mg/kg) in parts A–C of the study.
Part A: In situ ethanol exposure and infarction. A major
branch of the left coronary artery was prepared with a snare.
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Catheters filled with heparinized saline (10 U/ml) were
placed into the left carotid artery to monitor arterial blood
pressure and into the right jugular vein to withdraw blood
samples and administer drugs. Arterial pH, PO2 and PCO2
were maintained within the physiological range (blood gas
analyzer ABL 5, Radiometer, Copenhagen, Denmark).
Throughout the experiment, additional anesthesia was admin-
istered as needed (5 to 15 mg pentobarbital/15 min). A heating
pad maintained rectal temperature between 38.5° and 39.5°C.
The rabbits were allowed to stabilize for 20 min after surgery
before the protocols were begun (Fig. 1). All hearts experi-
enced 30 min of regional ischemia followed by 3 h of
reperfusion. Either 0.35, 0.7, or 1.4 g/kg ethanol was infused
over 10 min, starting 20 min prior to the onset of ischemia.
To precondition the hearts, a 5-min period of regional
ischemia was followed by 20 min of reperfusion prior to the
index ischemia. In the IPC1ethanol group, 0.7 g/kg etha-
nol was infused during the first 10 min of the 20 min of
reperfusion. In the diazoxide group, a bolus of 10 mg/kg
diazoxide was given 11 min before ischemia. In the
diazoxide1ethanol group, the 10-min ethanol infusion
(0.7 g/kg) was started 1 min after the diazoxide bolus. In
this group, ischemia was produced directly after the end of
the ethanol infusion. In the genistein1staurosporine group,
genistein (5 mg/kg) and staurosporine (50 mg/kg) were
given as boluses 9 min and 5 min before ischemia, respec-
tively. In the ethanol1genistein1staurosporine group the
above protocol was preceded by a 10-min ethanol infusion
(0.7 g/kg) started 20 min prior to the onset of ischemia. In
the final group, ethanol (0.35 g/kg) was infused over 10 min
starting 1 h before the onset of ischemia.
Part B: In vitro ethanol exposure and infarction. A major
branch of the left coronary artery was prepared with a snare
as above. The heart was excised and perfused in the
Langendorff mode with Krebs-Henseleit buffer (CaCl2, 2.5;
NaCl, 118.5; KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2;
NaHCO3, 24.8, and glucose 10 mmol/liter). Perfusion
pressure was set at 75 mm Hg. A saline-filled latex balloon
connected to a pressure transducer (Maxxim Medical, Ath-
ens, Texas) was inserted into the left ventricle. Baseline
end-diastolic pressure was set at 5 mm Hg. Hearts were
paced at 200 beats/min if the spontaneous rate was slower.
Isolated hearts were subjected to 30 min of regional ische-
mia and 2 h of reperfusion. Ethanol was infused for 5 min
at either 10, 20, or 50 mmol/liter followed by a 10-min
Abbreviations and Acronyms
ANOVA 5 one-way analysis of variance
IPC 5 ischemic preconditioning
IV 5 intravenous
PKC 5 protein kinase C
Figure 1. Experimental protocols in in situ preparations (part A). Timing
of the different interventions is shown in relation to the index ischemia.
IPC 5 ischemic preconditioning.
Figure 2. Experimental protocols in the in vitro and hybrid preparations
(parts B and C). Timing of the different interventions is shown in relation
to the index ischemia.
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washout period prior to ischemia (Fig. 2). In the two groups
with long ethanol exposure, either 10 or 50 mmol/liter
ethanol was infused for 45 min beginning 15 min before the
onset of ischemia.
Part C: Hybrid preparation of in situ ethanol exposure
followed by in vitro infarction. Rabbits were surgically
prepared as described for part A and received either no
infusion for control studies or an IV infusion of ethanol
(0.7 g/kg) over 10 min. Ten minutes later the heart was
excised and perfused with ethanol-free Krebs-Henseleit
buffer as described for part B. After 10 min of stabilization
after mounting, the hearts experienced 30 min of regional
ischemia and 2 h of reperfusion (Fig. 2).
SERUM ETHANOL. Serum ethanol concentrations in part A
were measured with a diagnostic test kit (Sigma Diagnos-
tics, St. Louis, Missouri).
RISK ZONE AND INFARCT SIZE. After completion of studies
all suspended hearts were perfused with 0.9% saline. Next,
the coronary snare was retightened, and 1–10-mm zinc
cadmium sulfide fluorescent particles (Duke Scientific, Palo
Alto, California) were infused to delineate the nonfluores-
cent area at risk. Hearts were frozen, cut into 2-mm
transverse slices, incubated for 20 min in 1% triphenyltet-
razolium chloride in 100 mmol/liter phosphate buffer (pH
7.4, 37°C), and immersed in 10% formalin. The borders
between fluorescent and nonfluorescent regions were
marked under ultraviolet light to identify the risk zone.
Infarct and risk zone areas were planimetered. Infarct size is
presented as a percent of risk zone.
Chemicals. For part A, diazoxide (Research Biochemicals
International, Natick, Massachusetts) and staurosporine
(Sigma Chemical, St. Louis, Missouri) were each dissolved
in 1 ml dimethyl sulfoxide. Genistein (Alexis, San Diego,
California) was prepared in a 1:1:2 solution of ethylene
glycol (PEG 400), ethanol, and 0.9% saline solution. In
parts A and C, 95% v/v ethanol (Fisher Scientific, Fair
Lawn, New Jersey) was infused intravenously. For part B,
95% v/v ethanol was diluted in Krebs buffer.
Statistics. Data are expressed as mean 6 SEM. One-way
analysis of variance (ANOVA) combined with Tukey’s post
hoc test was used to test for differences in infarct size and
baseline hemodynamics between groups. For differences in
hemodynamics within groups, ANOVA with replication
was used. For all tests, p , 0.05 was considered significant
(SYSTAT, Version 5.0).
RESULTS
Part A: In situ ethanol exposure and infarction. Body
weight, heart weight and size of risk zone were not different
between groups (data not shown). Baseline hemodynamics
were not different among groups (Table 1). Three doses of
ethanol (0.35, 0.7, and 1.4 g/kg) were tested. Infusion of
ethanol did not change heart rate and blood pressure.
Diazoxide decreased blood pressure.
Infarct size in untreated hearts was 40.4 6 3.1% of the
risk zone (Fig. 3). A 10-min infusion of ethanol started
20 min prior to the onset of ischemia at the doses of 0.35,
0.7, and 1.4 g/kg did not limit infarct size (44.0 6 3.0,
Table 1. Hemodynamics in Part A (In Situ Preparation)
Group Baseline Treatment
30-Min
Ischemia
30-Min
Reperfusion
Heart rate (beats/min)
Control 312 6 14 320 6 18 340 6 20
0.35 g/kg Ethanol 292 6 5 287 6 4 279 6 7* 281 6 6*
0.7 g/kg Ethanol 321 6 33 329 6 27 330 6 22 327 6 13
1.4 g/kg Ethanol 303 6 14 322 6 10 327 6 15* 330 6 17*
Ischemic preconditioning 296 6 5 306 6 6 325 6 7 322 6 6*
Ischemic preconditioning 1 ethanol 287 6 12 310 6 18 326 6 18* 310 6 16*
Diazoxide 304 6 15 315 6 13 318 6 14 310 6 14
Diazoxide 1 ethanol 288 6 8 304 6 16 324 6 20 320 6 15*
Staurosporine 1 genistein 295 6 5 283 6 5* 275 6 6* 264 6 12*
Ethanol 1 staurosporine 1 genistein 296 6 3 291 6 6 265 6 8* 270 6 4*
0.35 g/kg Ethanol 1 h pre-ischemia 278 6 12 280 6 10 267 6 9 276 6 12
Peak arterial pressure (mm Hg)
Control 108 6 5 99 6 5 87 6 10
0.35 g/kg Ethanol 101 6 3 103 6 3 83 6 4* 83 6 3*
0.7 g/kg Ethanol 96 6 6 98 6 6 92 6 6 83 6 8
1.4 g/kg Ethanol 95 6 3 102 6 9 81 6 11 76 6 12
Ischemic preconditioning 105 6 5 100 6 5 95 6 6 90 6 4
Ischemic preconditioning 1 ethanol 97 6 6 96 6 12 86 6 7 74 6 12
Diazoxide 106 6 5 99 6 5* 97 6 6 96 6 4
Diazoxide 1 ethanol 100 6 5 84 6 7 92 6 5 94 6 4
Staurosporine 1 genistein 105 6 4 87 6 4* 85 6 9* 65 6 16*
Ethanol 1 staurosporine 1 genistein 116 6 5 104 6 6* 85 6 4* 78 6 5*
0.35 g/kg Ethanol 1 h pre-ischemia 103 6 4 98 6 5 85 6 4* 89 6 4*
Values are mean 6 SEM. *p , 0.05 vs. baseline.
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44.9 6 3.4, and 60.3 6 10.7%, respectively; Fig. 3).
However, 0.35 g/kg ethanol infused 1 h before ischemia
significantly reduced infarct size to 26.3 6 3.9% (Fig. 3),
suggesting that the ethanol serum level had to drop below a
certain threshold level by the onset of ischemia before
ethanol’s protection could be expressed. At the onset of
ischemia, ethanol serum levels were 126 6 11 mg/dl in the
group exposed to 1.4 g/kg ethanol, 64 6 5 mg/dl after
0.7 g/kg ethanol infusion, and 56 6 5 mg/dl (;12 mmol/
liter) following 0.35 g/kg ethanol. When 0.35 g/kg ethanol
was infused 1 h before ischemia, the ethanol serum level had
dropped to 28 6 2 mg/dl (;6 mmol/liter) at the onset of
ischemia.
We tested whether an IPC-like protective effect of
ethanol might have been masked by a nonspecific toxic
effect of the alcohol during ischemia. Administration of the
two potent IPC blockers staurosporine and genistein had no
effect on infarct size in the heart not exposed to ethanol
(42.0 6 5.7%, Fig. 4). Furthermore, infarct size was not
significantly increased by this combination in the presence
of ethanol (47.0 6 5.0%). If the putative IPC-like protec-
tion induced were being counterbalanced by a nonspecific
toxic effect, then elimination of any possible IPC by the
combination of staurosporine and genistein should have
unmasked the toxic effect. This was not seen.
Both IPC and diazoxide reduced infarct size in situ
(14.7 6 3.3 and 18.4 6 5.0%, respectively), but ethanol
abolished protection from both interventions (51.0 6 8.8
and 45.3 6 4.0%, respectively, Fig. 5).
Part B: In vitro ethanol exposure and infarction. Body
weight, heart weight and size of risk zone were not different
between groups (data not shown). The baseline hemody-
namics were also not different among groups (Table 2).
Fifty but not 20 or 10 mmol/liter ethanol reduced developed
pressure and coronary flow and increased heart rate. The
prolonged infusion of 50 mmol/liter ethanol depressed both
flow and pressure.
In control hearts, infarct size averaged 33.0 6 2.8% of the
risk zone (Fig. 6). Transient exposure to 10, 20, and 50
mmol/liter ethanol prior to ischemia reduced infarct size to
17.9 6 3.2, 18.4 6 3.5, and 16.8 6 3.4%, respectively.
When infusion was prolonged to include the ischemic
period, neither 10 nor 50 mmol/liter ethanol limited infarct
size (31.5 6 3.8 and 39 6 5.7%, respectively; Fig. 6).
Part C: In situ ethanol exposure followed by in vitro
infarction. In this protocol ethanol was infused intrave-
nously for 10 min prior to excision of the heart and
perfusion with ethanol-free buffer. When these in vitro
hearts underwent ischemia, infarction was reduced (8.8 6
2.7%; Fig. 7) as compared to that in hearts from untreated
rabbits (31.4 6 3.5%; Fig. 7). These data indicate that
ethanol has the capacity to precondition the in situ heart,
but effects of prolonged exposure can mask that protection.
Figure 3. Effect of ethanol (E) on infarct size in the in situ preparation
(part A). Open symbols, individual experiments; closed symbols, group
means 6 SEM. If the 10-min ethanol infusion were started 20 min prior
to ischemia, infarct size was not affected. In contrast, a 10-min infusion of
0.35 g/kg ethanol started 1 h prior to ischemia significantly reduced infarct
size in comparison to control. *p , 0.05 vs. Control.
Figure 4. Effects of ethanol (E) alone or with staurosporine (S) 1 genistein
(G) on infarct size in the in situ preparation (part A). Open symbols,
individual experiments; closed symbols, group means 6 SEM. Combining
genistein and staurosporine did not affect infarct size either in the absence
or presence of ethanol.
Figure 5. Effects of ethanol (E), ischemic preconditioning (IPC), and
diazoxide (D) on infarct size in the in situ preparation (part A). Open
symbols, individual experiments; closed symbols, group means 6 SEM.
Ethanol abolished the reduction in infarct size induced by either IPC or
diazoxide. *p , 0.05 vs. Control.
604 Krenz et al. JACC Vol. 37, No. 2, 2001
Washout Is Critical for Ethanol’s Cardioprotection February 2001:601–7
DISCUSSION
The present data indicate that only transient preischemic
ethanol exposure triggers cardioprotection in rabbits. When
ethanol is present above a certain threshold during ischemia
either in vitro or in situ, protection is lost. This loss of
protection appears to be the consequence of a specific
interference of ethanol with the mechanism of IPC.
Figure 6. Effects of ethanol (E) on infarct size in the in vitro preparation
(part B). Open symbols, individual experiments; closed symbols, group
means 6 SEM. Ten, 20, and 50 mmol/liter ethanol reduced infarct size
when washed out prior to ischemia, whereas protection was lost when
ethanol (10 or 50 mmol/liter) was continued throughout ischemia. *p ,
0.05 vs. Control.
Figure 7. Effects of ethanol infusion in the open-chest rabbit followed by
an ischemic insult in the Langendorff mode (hybrid preparation, part C).
Open symbols, individual experiments; closed symbols, group means 6
SEM. Ethanol exposure before excision of the hearts did confer protection
as compared to hearts removed from untreated rabbits.
Table 2. Hemodynamics in Parts B (In Vitro Preparation) and C (Hybrid Preparation)
Baseline Treatment
30-Min
Ischemia
30-Min
Reperfusion
Part B (in vitro)
Heart rate (beats/min)
Control 196 6 4 200 6 1 200 6 1
Ethanol 10 mmol/liter 208 6 5 207 6 5 213 6 6 205 6 10
Ethanol 20 mmol/liter 220 6 11 216 6 9 205 6 5 202 6 2
Ethanol 50 mmol/liter 225 6 11 234 6 11* 219 6 8 217 6 7
Ethanol long 10 mmol/liter 210 6 6 216 6 8 219 6 6 213 6 8
Ethanol long 50 mmol/liter 201 6 2 196 6 3 205 6 5 204 6 4
Developed pressure (mm Hg)
Control 102 6 5 38 6 5* 67 6 5*
Ethanol 10 mmol/liter 114 6 7 107 6 7 53 6 9* 72 6 5*
Ethanol 20 mmol/liter 103 6 5 99 6 7 63 6 6* 82 6 5*
Ethanol 50 mmol/liter 93 6 6 79 6 8* 49 6 5* 67 6 6*
Ethanol long 10 mmol/liter 123 6 5 98 6 5* 40 6 8* 63 6 7*
Ethanol long 50 mmol/liter 98 6 8 54 6 14* 21 6 4* 43 6 9*
Coronary flow (ml/min/g)
Control 7.8 6 0.6 4.3 6 0.5* 5.0 6 0.7*
Ethanol 10 mmol/liter 8.2 6 0.4 7.7 6 0.5 4.5 6 0.4* 5.5 6 0.4*
Ethanol 20 mmol/liter 7.1 6 0.4 6.1 6 0.5 4.5 6 0.5* 5.7 6 0.8*
Ethanol 50 mmol/liter 9.9 6 0.7 7.8 6 0.9* 5.2 6 0.3* 6.6 6 0.3*
Ethanol long 10 mmol/liter 8.8 6 0.7 7.4 6 0.6* 3.4 6 0.5* 5.6 6 0.8*
Ethanol long 50 mmol/liter 7.1 6 0.8 3.0 6 0.5* 1.7 6 0.3* 3.0 6 0.3*
Part C (hybrid preparation)
Heart rate (beats/min)
Control 216 6 8† 213 6 8 208 6 11
Ethanol 209 6 9† 216 6 11 213 6 16
Developed pressure (mm Hg)
Control 118 6 7† 67 6 10* 88 6 3*
Ethanol 104 6 9† 69 6 15 100 6 11
Coronary flow (ml/min/g)
Control 7.6 6 0.5† 4.7 6 0.5* 5.8 6 0.8*
Ethanol 8.6 6 0.8† 5.1 6 0.6* 6.0 6 0.7*
Values are mean 6 SEM. *p , 0.05 vs. baseline. †For part C, data after 10 min of buffer-perfusion in the Langendorff mode
are shown as baseline.
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Protection depends on the timing of ethanol exposure. If
the heart is exposed to a 5-min coronary occlusion and then
reperfused, it quickly adapts itself to become resistant to
infarction from a subsequently more severe ischemic insult
(9). This protection, termed classical preconditioning, lasts for
less than 1 h in anesthetized rabbits and then subsides (10).
Twenty-four hours later a second wave of preconditioning
appears, which is less potent but persists for several days (2).
Previous studies in isolated guinea pig (11,12) and rat (12)
hearts have demonstrated cardioprotection following
chronic ethanol exposure. Ethanol was fed to the animals
over many weeks and then withdrawn prior to study,
suggesting a delayed type of preconditioning. Recent studies
in rat hearts and cardiomyocytes (3) have revealed that acute
ethanol exposure could also offer protection by a mechanism
similar to that of classical preconditioning. However, infarct
size was not determined in these studies, thus making it
difficult to correlate ethanol’s protection to that of IPC.
In the present study, substitution of ethanol for a pre-
conditioning ischemic period followed by washout prior to
ischemia exerted a powerful anti-infarct effect in the isolated
rabbit heart. These data support the hypothesis that acute
ethanol exposure indeed mimics classical IPC. However,
this protection is conditional. Importantly, ethanol failed to
attenuate infarct size in the in situ rabbit model (part A)
when ischemia closely followed the alcohol infusion. These
findings are in concordance with a recent report from Itoya
et al. (5). In their study, ethanol was also given 10 min
before coronary artery occlusion in open-chest dogs, and
this did not affect infarct size. In both their study and our
experiments, ethanol serum levels were still high at the onset
of ischemia. As seen in the present study, ethanol was
capable of triggering a preconditioned state in the in situ
heart, as confirmed by the small infarcts in hearts removed
after ethanol infusion and subjected to ischemia in the
absence of ethanol (part C). Furthermore, when we infused
0.35 g/kg ethanol in the open-chest model and then waited
50 min before starting ischemia, ethanol serum levels
dropped sufficiently to remove the inhibitory effect of
ethanol and to allow appearance of the preconditioned state.
Ethanol administration may increase plasma cat-
echolamines and myocardial oxygen consumption in the in
situ model (13–15). This basic difference between in situ
and in vitro models, however, cannot totally explain the
effects of ethanol in our experiments because protection was
observed in the in situ protocol in which 50 min elapsed
between alcohol administration and ischemia.
The timing of ethanol exposure is critical for the agent’s
ability to reduce infarct size in situ. There seems to be a
distinct threshold (between 6 and 12 mmol/liter in the in
situ rabbit model) above which ethanol blocks its own
initially induced protection. The threshold for inducing
protection has yet to be determined. Chen et al. (3) observed
protection in rat cardiomyocytes acutely exposed to 10 to 50
mmol/liter ethanol and then subjected to simulated ische-
mia either in the presence or absence of ethanol. In a limited
series of three isolated rat hearts, exposure to 10 mmol/liter
ethanol before and throughout global ischemia was also
protective as assessed by creatine kinase release during
reperfusion (3). In the present study, we also exposed
isolated rabbit hearts to 10 mmol/liter ethanol. Short
exposure followed by washout prior to ischemia was protec-
tive. However, unlike the case with rat hearts, protection
was not evident when 10 mmol/liter ethanol was also
present during ischemia. The threshold for blocking IPC-
like behavior may well differ among species.
Ethanol exposure during ischemia interferes with the
signaling cascade of IPC. In our isolated heart experi-
ments, transient exposure to ethanol had an anti-infarct
effect that was equipotent with that of IPC. Isoform-
selective translocation and activation of PKC « is regarded
as a critical step in the signaling pathway of classical (4) and
delayed preconditioning in rabbits (16). Protection in rat
cardiomyocytes following preincubation with ethanol and
washout before ischemia was blocked by selective inhibition
of PKC « (3), as was protection from IPC (4).
Given the similarities between IPC and ethanol-induced
protection we tested whether the loss of protection observed
when ethanol was present during ischemia might have been
the result of interference with IPC’s signaling cascade. The
presence of high concentrations of ethanol during ischemia
completely blocked protection from IPC in our in situ
preparation, suggesting that ethanol during ischemia spe-
cifically blocks the IPC mechanism.
The combination of staurosporine and genistein produces
the most potent blockade of IPC’s protection documented
to date (17,18). Interestingly, the double blockade in the
presence of ethanol infusion did not increase infarct size
over that seen with ethanol alone. We had predicted that if
IPC-related protection were removed, we might unmask a
nonspecific toxic action of ethanol that would have then
extended the infarcts. Because extension of infarct was not
seen, we conclude that ethanol’s presence during ischemia
selectively blocked the IPC mechanism.
We attempted to determine at which step of the signaling
cascade of IPC does ethanol block protection. Ethanol
infusion in situ was combined with diazoxide, an opener of
mitochondrial KATP channels that are touted as end-
effectors of IPC (19–21), and ethanol blocked diazoxide’s
protection. If the mitochondrial KATP channels were the
end-effectors, then abrogation of diazoxide’s protection
would indicate an interaction with the channels themselves.
Unfortunately, there is new evidence that mitochondrial
KATP channels may not be the end-effectors of IPC, but
may only be an upstream link in the signaling cascade (22).
Clinical implications. Whether acute exposure to ethanol
will protect a patient’s (in situ) heart becomes very depen-
dent on the amount taken and the time before the onset of
ischemia. Previous studies have reported reduced coronary
mortality in individuals claiming moderate ethanol con-
sumption and also loss of this protection at higher levels of
consumption (23,24). Protection at moderate ethanol con-
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sumption is probably related to favorable effects on plasma
lipids and hemostasis (23,25), as well as to a possible delayed
preconditioning effect (1,11,12). However, the current find-
ings suggest that the presence of ethanol above some
threshold level during an ischemic episode will not only
abolish the alcohol’s own acute preconditioning-like protec-
tion, but will also block any other protection the patient may
have acquired. There is substantial evidence that a signifi-
cant number of patients with acute myocardial infarction
actually enjoy the benefits of a preconditioned state—be it
from antecedent angina (26), delayed preconditioning from
prior ethanol exposure, or drugs such as opioids (27). The
presence of ethanol would be expected to obviate such
effects, and, therefore, should be avoided in this setting.
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